Medtronic’s stock narrative has recently shifted, as reflected in a modest rise in the consensus analyst price target from ...

The medical-device giant is positioning its Hugo RAS system to compete with Intuitive Surgical's da Vinci systems.

The companies agreed to enhance access to technology from DASI, a leader in AI-driven predictive modeling and digital twin ...

In the last decade, Medtronic (MDT) stock has returned a notable $52 Bil back to its shareholders through cold, hard cash via ...

The Minnesota medtech company’s Altaviva implant just secured FDA approval. It treats urinary urge incontinence, a ...

The firm stated that Medtronic plc (NYSE:MDT) seems “confidently ready” from the standpoints of manufacturing, supply chain, ...

With positive trial results in urology and hernia repair already under its belt, the company is getting closer to taking on ...

Litigation over Medtronic Plc’s alleged scheme to avoid $100 million in deal payments by sabotaging sales of a reusable ...

Medtronic (NYSE: MDT) announced today that it received new labeling approval from the FDA for its Endurant stent graft system.

Globe Investor value reports provide a daily price target for more than 9,000 stocks on the TSX, Nasdaq, and NYSE. Used by Bay Street pros, advisors and Canadians who invest on their own, they help ...

Medtronic has initiated the Embrace Gynecology study in the US to assess the Hugo robotic-assisted surgery (RAS) system.

Medtronic (NYSE:MDT) strengthens its healthcare offerings. Key sectors of Medtronic show growth. S&P 500 futures reflects trends in healthcare. Medtronic plc (NYSE:MDT) is a global leader in medical ...